BOSTON, July 30, 2020 (GLOBE NEWSWIRE) — resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target […]
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]
Reports record quarterly revenue of $87.5 millionOverall revenue grew 24% year-over-year, with organic growth of 19%Raises revenue guidance to $332-$340 […]
– Rilonacept pivotal Phase 3 trial in recurrent pericarditis met statistical significance for primary and all major secondary efficacy endpoints; sBLA […]